_creationDate | September 16, 2024 |
_modificationDate | September 16, 2024 |
_creator | Si787 |
_fullText | {{ServiceRequestCase
|requisition=Liver Neoplasm Outs - 9/16/2024
|subject=MGH
|intent=order
|category=409073007
|occurrenceDateTime=2024-09-20 12:00:00-04:00
|basedOn=WSI24-200
|priority=Routine
|code=apdidactic
|orderDetail=case
|authoredOn=2024-09-16 20:07:52.122101+00:00
|requester=Az375
|locati ... |
_numRevisions | 3 |
_isRedirect | No |
identifier | WSI24-200-Case-4 |
basedOn | WSI24-200 |
requisition | Liver Neoplasm Outs - 9/16/2024 |
intent | order |
category | 409073007 |
priority | Routine |
code | apdidactic |
orderDetail | case |
subject | MGH |
occurrenceDateTime | September 20, 2024 12:00:00 PM |
authoredOn | September 16, 2024 4:07:52 PM |
requester | Az375 |
performer | Az375 |
locationCode | learn |
reasonCode | 50yo woman with a history of breast cancer and thyroid cancer • presences with a 1 cm liver lesion suspicious for metastasis |
supportingInfo | Hepatocellular adenoma • inflammatory subtype |
specimen | null |
bodySite | null |
sequence | 4 |
access | public |
identifier | 772a4a09-c213-4a4b-9129-c6242cfa9460 |
basedOn | WSI24-200-Case-4 |
partOf | WSI24-200 |
status | completed |
type | null |
modality | mrxs |
view | hide |
operator | Az375 |
reasonCode | Beta-catenin |
bodySite | null |
frames | 1 |
content | 772a4a09-c213-4a4b-9129-c6242cfa9460.mrxs |
note | null |
subject | null |
identifier | 1055a5c9-b133-497e-97fe-dc6ef7e8ccc8 |
basedOn | WSI24-200-Case-4 |
partOf | WSI24-200 |
status | completed |
type | null |
modality | mrxs |
view | hide |
operator | Az375 |
reasonCode | Glutamine synthetase (GS) |
bodySite | null |
frames | 2 |
content | 1055a5c9-b133-497e-97fe-dc6ef7e8ccc8.mrxs |
note | null |
subject | null |
identifier | e393dfb0-df3a-4b34-b393-60720144c931 |
basedOn | WSI24-200-Case-4 |
partOf | WSI24-200 |
status | completed |
type | null |
modality | mrxs |
view | hide |
operator | Az375 |
reasonCode | Fatty acid binding protein (FABP1) |
bodySite | null |
frames | 3 |
content | e393dfb0-df3a-4b34-b393-60720144c931.mrxs |
note | null |
subject | null |
identifier | 69bd61e1-c10a-4239-9499-6aba2c54ebd8 |
basedOn | WSI24-200-Case-4 |
partOf | WSI24-200 |
status | completed |
type | null |
modality | mrxs |
view | hide |
operator | Az375 |
reasonCode | Serum amyloid A (SAA1) |
bodySite | null |
frames | 4 |
content | 69bd61e1-c10a-4239-9499-6aba2c54ebd8.mrxs |
note | null |
subject | null |
identifier | a1271068-281a-4c2d-96ff-bcdd66a241b8 |
basedOn | WSI24-200-Case-4 |
partOf | WSI24-200 |
status | completed |
type | null |
modality | mrxs |
view | hide |
operator | Az375 |
reasonCode | Serum amyloid A (SAA1) |
bodySite | null |
frames | 5 |
content | a1271068-281a-4c2d-96ff-bcdd66a241b8.mrxs |
note | null |
subject | null |
identifier | b5bf5c0e-3682-47f3-94dc-3341061eeb88 |
basedOn | WSI24-200-Case-4 |
partOf | WSI24-200 |
status | completed |
type | null |
modality | mrxs |
view | show |
operator | Az375 |
reasonCode | H&E |
bodySite | null |
frames | 6 |
content | b5bf5c0e-3682-47f3-94dc-3341061eeb88.mrxs |
note | null |
subject | null |
identifier | 5966b100-50ed-42cd-8c88-f2628f9efa79 |
basedOn | WSI24-200-Case-4 |
partOf | WSI24-200 |
status | completed |
type | null |
modality | mrxs |
view | show |
operator | Az375 |
reasonCode | H&E |
bodySite | null |
frames | 7 |
content | 5966b100-50ed-42cd-8c88-f2628f9efa79.mrxs |
note | null |
subject | null |
status | active |
identifier | WSI24-200-Case-4 |
requester | Az375 |
authoredOn | September 16, 2024 4:07:52 PM |